Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Equity (2021 - 2025)

Historic Return on Equity for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to 0.17%.

  • Krystal Biotech's Return on Equity rose 800.0% to 0.17% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.17%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.19% for FY2025, which is 900.0% up from last year.
  • According to the latest figures from Q4 2025, Krystal Biotech's Return on Equity is 0.17%, which was up 800.0% from 0.18% recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Return on Equity ranged from a high of 0.18% in Q3 2025 and a low of 0.27% during Q1 2023
  • For the 5-year period, Krystal Biotech's Return on Equity averaged around 0.03%, with its median value being 0.01% (2023).
  • Per our database at Business Quant, Krystal Biotech's Return on Equity crashed by -1200bps in 2022 and then surged by 3800bps in 2024.
  • Krystal Biotech's Return on Equity (Quarter) stood at 0.14% in 2021, then tumbled by -90bps to 0.26% in 2022, then skyrocketed by 105bps to 0.01% in 2023, then soared by 583bps to 0.1% in 2024, then skyrocketed by 78bps to 0.17% in 2025.
  • Its Return on Equity was 0.17% in Q4 2025, compared to 0.18% in Q3 2025 and 0.14% in Q2 2025.